TY - JOUR
T1 - Genetic determinants of lung cancer prognosis in never smokers
T2 - A pooled analysis in the international lung cancer consortium
AU - Brhane, Yonathan
AU - Yang, Ping
AU - Christiani, David C.
AU - Liu, Geoffrey
AU - McLaughlin, John R.
AU - Brennan, Paul
AU - Shete, Sanjay
AU - Field, John K.
AU - Tardon, Adonina
AU - Kohno, Takashi
AU - Shiraishi, Kouya
AU - Matsuo, Keitaro
AU - Bosse, Yohan
AU - Amos, Christopher I.
AU - Hung, Rayjean J.
N1 - Funding Information:
The genetic data generation was supported by U.S. NIH U19 CA148127, and the analysis was supported by U19 CA203654 and CIHR FDN 167273. The Mayo Clinic Study is supported by NIH grants CA77118/CA80127/CA84354 and Mayo Foundation. Support was provided by the Mayo Clinic Shared Resources.
Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Background: Lung cancer remains the leading cause of cancer death worldwide, with 15% to 20% occurring in never smokers. To assess genetic determinants for prognosis among never smokers, we conducted a genome-wide investigation in the International Lung Cancer Consortium (ILCCO). Methods: Genomic and clinical data from 1,569 never-smoking patients with lung cancer of European ancestry from 10 ILCCO studies were included. HRs and 95% confidence intervals of overall survival were estimated. We assessed whether the associations were mediated through mRNA expression–based 1,553 normal lung tissues from the lung expression quantitative trait loci (eQTL) dataset and Genotype-Tissue Expression (GTEx). For cross-ethnicity generalization, we assessed the associations in a Japanese study (N ¼ 887). Results: One locus at 13q22.2 was associated with lung adenocarcinoma survival at genome-wide level, with carriers of rs12875562-T allele exhibiting poor prognosis [HR ¼ 1.71 (1.41–2.07), P ¼ 3.60 10-8], and altered mRNA expression of LMO7DN in lung tissue (GTEx, P ¼ 9.40 10-7; Lung eQTL dataset, P ¼ 0.003). Furthermore, 2 of 11 independent loci that reached the suggestive significance level (P < 10-6) were significant eQTL affecting mRNA expression of nearby genes in lung tissues, including CAPZB at 1p36.13 and UBAC1 at 9q34.3. One locus encoding NWD2/KIAA1239 at 4p14 showed associations in both European [HR ¼ 0.50 (0.38–0.66), P ¼ 6.92 10-7] and Japanese populations [HR ¼ 0.79 (0.67–0.94), P ¼ 0.007]. Conclusions: Based on the largest genomic investigation on the lung cancer prognosis of never smokers to date, we observed that lung cancer prognosis is affected by inherited genetic variants. Impact: We identified one locus near LMO7DN at genome-wide level and several potential prognostic genes with cis-effect on mRNA expression. Further functional genomics work is required to understand their role in tumor progression.
AB - Background: Lung cancer remains the leading cause of cancer death worldwide, with 15% to 20% occurring in never smokers. To assess genetic determinants for prognosis among never smokers, we conducted a genome-wide investigation in the International Lung Cancer Consortium (ILCCO). Methods: Genomic and clinical data from 1,569 never-smoking patients with lung cancer of European ancestry from 10 ILCCO studies were included. HRs and 95% confidence intervals of overall survival were estimated. We assessed whether the associations were mediated through mRNA expression–based 1,553 normal lung tissues from the lung expression quantitative trait loci (eQTL) dataset and Genotype-Tissue Expression (GTEx). For cross-ethnicity generalization, we assessed the associations in a Japanese study (N ¼ 887). Results: One locus at 13q22.2 was associated with lung adenocarcinoma survival at genome-wide level, with carriers of rs12875562-T allele exhibiting poor prognosis [HR ¼ 1.71 (1.41–2.07), P ¼ 3.60 10-8], and altered mRNA expression of LMO7DN in lung tissue (GTEx, P ¼ 9.40 10-7; Lung eQTL dataset, P ¼ 0.003). Furthermore, 2 of 11 independent loci that reached the suggestive significance level (P < 10-6) were significant eQTL affecting mRNA expression of nearby genes in lung tissues, including CAPZB at 1p36.13 and UBAC1 at 9q34.3. One locus encoding NWD2/KIAA1239 at 4p14 showed associations in both European [HR ¼ 0.50 (0.38–0.66), P ¼ 6.92 10-7] and Japanese populations [HR ¼ 0.79 (0.67–0.94), P ¼ 0.007]. Conclusions: Based on the largest genomic investigation on the lung cancer prognosis of never smokers to date, we observed that lung cancer prognosis is affected by inherited genetic variants. Impact: We identified one locus near LMO7DN at genome-wide level and several potential prognostic genes with cis-effect on mRNA expression. Further functional genomics work is required to understand their role in tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=85102237209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102237209&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-20-0248
DO - 10.1158/1055-9965.EPI-20-0248
M3 - Article
C2 - 32699080
AN - SCOPUS:85102237209
SN - 1055-9965
VL - 29
SP - 1983
EP - 1992
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 10
ER -